Research Portfolio

OICR’s Investigator Awards Program has attracted outstanding PhD researchers and clinician-scientists to Ontario from across Canada and around the world. The program provides stable recruitment and retention funding for principal investigators in Ontario, further strengthening the province’s cancer research capacity.

Jump to: Technology programs | Translational Research Initiatives | Global Leadership in Precision Oncology | Collaborative Research Networks

Rima Al-awar

Director, Drug Discovery Program

The major goal of the Drug Discovery group is to optimize lead molecules and progress them to drug candidates that can translate into therapeutic benefits to cancer patients.

Laurie Ailles

Principal Investigator

Dr. Ailles' lab hopes to develop a greater understanding of how cancer stem cells work. With this understanding researchers will be able to eliminate cancer stem cells and create new therapies that can stop the development of tumours.

Rima Al-awar

Director, Drug Discovery Program

The major goal of the Drug Discovery group is to optimize lead molecules and progress them to drug candidates that can translate into therapeutic benefits to cancer patients.

Laurie Ailles

Principal Investigator

Dr. Ailles' lab hopes to develop a greater understanding of how cancer stem cells work. With this understanding researchers will be able to eliminate cancer stem cells and create new therapies that can stop the development of tumours.

Rima Al-awar

Director, Drug Discovery Program

 The major goal of the Drug Discovery group is to optimize lead molecules and progress them to drug candidates that can translate into therapeutic benefits to cancer patients.


This is a little addition to the page....